| 
									
										| 
												
													
													| 
															
				
															
															
															
					| Hemophilia: Treatment for People Who Have Inhibitors
		
			| Hemophilia: Treatment for People Who Have InhibitorsSkip to the navigationTopic OverviewWhat are inhibitors?Some people who have
		hemophilia A  develop antibodies to the injected
		clotting factor. The body thinks that
		the replacement clotting factors don't belong in the body, so it creates
		the antibodies, also called inhibitors,  to get rid of them.  Inhibitors may make it harder to treat bleeding episodes because the
		body's natural defense system (immune system) interferes with the
		function of replacement clotting factors.   Some
		people produce few inhibitors; others produce many. How can I be treated?If you have inhibitors, hemophilia treatment may require
		specially engineered replacement clotting factors. Other treatment for clotting
		factor inhibitors includes therapy to suppress the immune system
		(immunosuppressive therapy). If you have a larger amount of inhibitors, you might be treated with: Factor bypassing agents. These clotting factors are used
		  to skip the part of the clotting process that requires either clotting factor
		  VIII or IX. This treatment is unpredictable, and it is hard to determine the
		  correct dose.  This treatment also slightly increases
		  your risk of having a heart attack or developing blood clots.A
		  regimen that allows the body to get used to the clotting factors so that they
		  won't produce as many or any inhibitors. This is done by giving large amounts
		  of clotting factors daily over an extended period of time.
		  During the first part of the treatment, you will get a factor bypassing agent
		  along with the regular clotting factors to make sure that any injury will heal.
		  After the body starts getting used to the clotting factors, the bypassing agent
		  is no longer needed.
 If your body produces few inhibitors in reaction to clotting
		factors,
		you may be treated with clotting factor concentrate that is made in a lab (recombinant clotting factors). You might get large doses of the clotting factors, which can
		  overwhelm the inhibitors.ReferencesOther Works ConsultedRoberts HR, et al. (2010). Hemophilia A and hemophilia B. In K Kaushansky et al., eds., Williams Hematology, 8th ed., pp. 2009-2029. New York: McGraw-Hill.
CreditsByHealthwise StaffPrimary Medical ReviewerE. Gregory Thompson, MD - Internal Medicine
 Adam Husney, MD - Family Medicine
 Martin J. Gabica, MD - Family Medicine
 Specialist Medical ReviewerBrian Leber, MDCM, FRCPC - Hematology
Current as ofOctober 13, 2016Current as of:
                October 13, 2016 Last modified on: 8 September 2017  |  |  |  |  |  |